Elevai Labs Inc (ELAB)

[MartinLutherKing]

More hitting wires
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
January 15 2025 - 9:30AM


Share On Facebook

PMGC Holdings Inc. (formerly Elevai Labs Inc.) (the “Company” or “PMGC”) (Nasdaq: ELAB) is pleased to announce the renaming of its wholly owned subsidiaries as part of a strategic effort to better align with the company's evolving business focus as a diversified holding company. Effective immediately, the following name changes have taken place:
Elevai Research Inc. is now PMGC Research Inc.
Elevai Biosciences, Inc. is now Northstrive Biosciences Inc.
About PMGC Research Inc. (formerly Elevai Research Inc.)

PMGC Research Inc. is a research and development subsidiary of PMGC Holdings Inc. focused on advancing the frontiers of scientific discovery. Currently, the company is leveraging Canadian research grants and partnering with leading Canadian universities to push the boundaries of innovation in the biosciences field. Through strategic collaborations, PMGC Research Inc. is dedicated to transforming scientific breakthroughs into real-world solutions that improve health and well-being.

About Northstrive Biosciences Inc. (formerly Elevai Biosciences, Inc.)

Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Our lead asset, EL-22 is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.

For more information, please visit www.northstrivebio.com.

Both PMGC Research Inc. and Northstrive Biosciences Inc. continue to focus on driving innovation and delivering transformative solutions in their respective fields.

For more information on PMGC Holdings Inc. and its subsidiaries, please visit www.pmgcholdings.com

About PMGC Holdings Inc.

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. Currently, our portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. We are committed to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.